Latest filing published 13 Jun 2008 for Interpace Biosciences, INC., €11k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Marquard: trading record in brief
This profile gathers the share dealings of Michael Marquard in Interpace Biosciences, Inc. We count 5 filings; the first trade dates from 30 March 2007 and the latest from 11 June 2008.
Every open-market trade on record is a purchase: 2 purchases worth €13k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. In 2008 alone, the filings show 2 purchases and no sales.
The newest entry dates from 13 June 2008: an open-market purchase of €11k, in Interpace Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Marquard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,084 shares@ US$7.99Common StockSEC:0001140361-08-014952:0Canonical exit: 9 Sept 2008 (T+90)
- 416 shares@ US$7.98Common StockSEC:0001140361-08-014952:1Canonical exit: 9 Sept 2008 (T+90)
- 11,244 sharesCommon StockSEC:0001140361-08-014827:0
- 32,342 shares@ US$7.73Common StockSEC:0001140361-08-005491:0
- 26,261 shares@ US$9.52Common StockSEC:0001140361-07-006978:0
5 of 5 declarations